| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S004010100414 |
| P698 | PubMed publication ID | 11761721 |
| P2093 | author name string | David G | |
| Wesseling P | |||
| Verbeek MM | |||
| van den Heuvel LP | |||
| de Waal RM | |||
| Maat-Schieman ML | |||
| van Horssen J | |||
| Otte-Höller I | |||
| P433 | issue | 6 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| heparan sulfate proteoglycans | Q66589633 | ||
| P304 | page(s) | 604-614 | |
| P577 | publication date | 2001-12-01 | |
| P1433 | published in | Acta Neuropathologica | Q343168 |
| P1476 | title | Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains. | |
| P478 | volume | 102 |
| Q58756018 | Advanced fabrication of biosensor on detection of Glypican-1 using S-Acetylmercaptosuccinic anhydride (SAMSA) modification of antibody |
| Q30846817 | Amelioration of amyloid-β-induced deficits by DcR3 in an Alzheimer's disease model |
| Q35970547 | Amyloid accomplices and enforcers |
| Q37241399 | Amyloid-β Precursor Protein Modulates the Sorting of Testican-1 and Contributes to Its Accumulation in Brain Tissue and Cerebrospinal Fluid from Patients with Alzheimer Disease |
| Q39155261 | Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins |
| Q48939701 | Apolipoprotein E genotype regulates amyloid-beta cytotoxicity. |
| Q55027631 | Brain Transcriptomic Analysis of Hereditary Cerebral Hemorrhage With Amyloidosis-Dutch Type. |
| Q37228777 | Brain extracellular matrix in neurodegeneration |
| Q91892434 | Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways |
| Q61800926 | Contribution of syndecans to cellular internalization and fibrillation of amyloid-β(1-42) |
| Q46323407 | Critical Influence of Cosolutes and Surfaces on the Assembly of Serpin-Derived Amyloid Fibrils. |
| Q27331411 | Disruption of arterial perivascular drainage of amyloid-β from the brains of mice expressing the human APOE ε4 allele |
| Q36643093 | Endothelial Dysfunction and Amyloid-β-Induced Neurovascular Alterations. |
| Q36961152 | Heat shock proteins and amateur chaperones in amyloid-Beta accumulation and clearance in Alzheimer's disease |
| Q37784314 | Heparan Sulfate Proteoglycans in Amyloidosis |
| Q39755348 | Heparan sulfate mediates amyloid-beta internalization and cytotoxicity |
| Q36489864 | Heparan sulfate proteoglycans mediate Aβ-induced oxidative stress and hypercontractility in cultured vascular smooth muscle cells |
| Q35183966 | Heparan sulphate proteoglycans in Alzheimer's disease and amyloid-related disorders |
| Q34727104 | Juvenile traumatic brain injury induces long-term perivascular matrix changes alongside amyloid-beta accumulation. |
| Q36161798 | Kainic acid-mediated excitotoxicity as a model for neurodegeneration |
| Q53482562 | Liver X Receptor Agonist Modifies the DNA Methylation Profile of Synapse and Neurogenesis-Related Genes in the Triple Transgenic Mouse Model of Alzheimer's Disease. |
| Q48421288 | Molecular chaperons, amyloid and preamyloid lesions in the BRI2 gene-related dementias: a morphological study |
| Q24297568 | Mostly separate distributions of CLAC- versus Abeta40- or thioflavin S-reactivities in senile plaques reveal two distinct subpopulations of beta-amyloid deposits |
| Q33908201 | Neuronal heparan sulfates promote amyloid pathology by modulating brain amyloid-β clearance and aggregation in Alzheimer's disease |
| Q48365948 | Pathological changes in basement membranes and dermal connective tissue of skin from patients with hereditary cystatin C amyloid angiopathy. |
| Q38313097 | Perlecan domain V inhibits amyloid-β induced brain endothelial cell toxicity and restores angiogenic function |
| Q24301330 | Prion, amyloid beta-derived Cu(II) ions, or free Zn(II) ions support S-nitroso-dependent autocleavage of glypican-1 heparan sulfate |
| Q26865932 | Proteoglycans in the central nervous system: role in development, neural repair, and Alzheimer's disease |
| Q44428500 | Proteoglycans synthesized and secreted by pancreatic islet beta-cells bind amylin |
| Q54919106 | Proteolytic Remodeling of Perineuronal Nets: Effects on Synaptic Plasticity and Neuronal Population Dynamics. |
| Q35674780 | Resorufin analogs preferentially bind cerebrovascular amyloid: potential use as imaging ligands for cerebral amyloid angiopathy |
| Q92854187 | Review of Alterations in Perlecan-Associated Vascular Risk Factors in Dementia |
| Q39017769 | Role of Matricellular Proteins in Disorders of the Central Nervous System. |
| Q37771918 | Role of proteoglycans and glycosaminoglycans in the pathogenesis of Alzheimer's disease and related disorders: amyloidogenesis and therapeutic strategies--a review |
| Q45918188 | Sulfation of heparan sulfate associated with amyloid-beta plaques in patients with Alzheimer's disease. |
| Q35144959 | Suppression of amyloid beta A11 antibody immunoreactivity by vitamin C: possible role of heparan sulfate oligosaccharides derived from glypican-1 by ascorbate-induced, nitric oxide (NO)-catalyzed degradation |
| Q48359750 | TGFβ pathway deregulation and abnormal phospho-SMAD2/3 staining in hereditary cerebral hemorrhage with amyloidosis-Dutch type |
| Q37736091 | Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage. |
| Q38223223 | The potential role of perlecan domain V as novel therapy in vascular dementia |
| Q38441061 | Wnt Signaling Cascades and the Roles of Syndecan Proteoglycans |
Search more.